These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23124289)

  • 21. The immune response induced by hepatitis B virus principal antigens.
    Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
    Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
    Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection.
    Shimizu Y
    World J Gastroenterol; 2012 May; 18(20):2443-51. PubMed ID: 22654441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological cure of HBV infection.
    Lang J; Neumann-Haefelin C; Thimme R
    Hepatol Int; 2019 Mar; 13(2):113-124. PubMed ID: 30600480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopathogenesis of Hepatitis B Virus.
    Tseng TC; Huang LR
    J Infect Dis; 2017 Nov; 216(suppl_8):S765-S770. PubMed ID: 29156047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection.
    Hoogeveen RC; Boonstra A
    Front Immunol; 2020; 11():401. PubMed ID: 32194573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus: from immunobiology to immunotherapy.
    Grimm D; Heeg M; Thimme R
    Clin Sci (Lond); 2013 Jan; 124(2):77-85. PubMed ID: 23013042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune balance in Hepatitis B Infection: Present and Future Therapies.
    Vyas AK; Jindal A; Hissar S; Ramakrishna G; Trehanpati N
    Scand J Immunol; 2017 Jul; 86(1):4-14. PubMed ID: 28387980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression.
    Khanam A; Chua JV; Kottilil S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular basis of the failed immune response in chronic HBV: therapeutic implications.
    Maini MK; Schurich A
    J Hepatol; 2010 Apr; 52(4):616-9. PubMed ID: 20185199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of HBV immune evasion.
    Kuipery A; Gehring AJ; Isogawa M
    Antiviral Res; 2020 Jul; 179():104816. PubMed ID: 32387476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D; Sansas B; Jiang JH; Gong QM; Jin GD; Calais V; Yu DM; Zhu MY; Wei D; Zhang DH; Inchauspé G; Zhang XX; Zhu R
    J Viral Hepat; 2017 Nov; 24 Suppl 1():66-74. PubMed ID: 29082648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
    Carotenuto P; Artsen A; Niesters HG; Osterhaus AD; Pontesilli O
    J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunopathogenesis of hepatitis B virus infection.
    Chang JJ; Lewin SR
    Immunol Cell Biol; 2007 Jan; 85(1):16-23. PubMed ID: 17130898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
    Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
    BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic vaccination and novel strategies to treat chronic HBV infection.
    Bertoletti A; Gehring A
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):561-9. PubMed ID: 19817676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBV and the immune response.
    Ferrari C
    Liver Int; 2015 Jan; 35 Suppl 1():121-8. PubMed ID: 25529097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Lobaina Y; Michel ML
    Vaccine; 2017 Apr; 35(18):2308-2314. PubMed ID: 28351734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of Hepatitis B Virus Persistence.
    Tsai KN; Kuo CF; Ou JJ
    Trends Microbiol; 2018 Jan; 26(1):33-42. PubMed ID: 28823759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.